Actively Recruiting
Ablation of Pulmonary Oligometastasis Combined With System for Advanced Hepatocellular Carcinoma
Led by Sun Yat-sen University · Updated on 2024-12-03
470
Participants Needed
1
Research Sites
64 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Ablation has been an effective therapy in treating intrathoracic metastases. However, for hepatocellular carcinoma with pulmonary oligometastasis, ablation of metastases remains relatively unexplored and still needs clinical evidence.
CONDITIONS
Official Title
Ablation of Pulmonary Oligometastasis Combined With System for Advanced Hepatocellular Carcinoma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of primary hepatocellular carcinoma confirmed histologically or clinically
- Presence of pulmonary oligometastasis found within three months of HCC diagnosis
- Metastases limited to five sites or fewer and involving no more than two organs, each with maximum diameter of 5 cm
- Received first-line systemic therapy for at least 3 months before ablation with controlled intrahepatic tumors and no progression of metastases
- Underwent locoregional treatments such as transarterial chemoembolization or hepatic arterial infusion chemotherapy
- Classified as Child-Pugh class A or B and ECOG performance status 0 or 1
- No history of other malignancies
- Life expectancy longer than 3 months
- Agreed to participate in this clinical trial
- Blood counts and liver/kidney function within specified normal limits
You will not qualify if you...
- Intermediate hepatocellular carcinoma
- Age under 18 years or over 75 years
- Advanced HCC with more than five metastases
- No response to Lenvatinib treatment
- Metastases larger than 5 cm
- Life expectancy less than 3 months
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Chinese PLA General hospital
Beijing, Beijing Municipality, China, 100853
Actively Recruiting
Research Team
Q
Qunfang Zhou, MD
CONTACT
F
Feng Duan, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here